Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Blood Vessels, Thrombosis & Hemostasis|March 19, 2026
Intracranial hemorrhage in patients with primary brain cancer receiving anticoagulationEva N Hamulyák, Tzu-Fei Wang, Lisa Baumann Kreuziger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 10, 2024
Protocol compliance in a multicentric phase III trial investigating scheduled adaptive radiotherapy and dose painting in head and neck cancerAnna Liza M P de Leeuw, Jordi Giralt, Yungan Tao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 18, 2024
A multicentric randomized controlled phase III trial of adaptive and 18F-FDG-PET-guided dose-redistribution in locally advanced head and neck squamous cell carcinoma (ARTFORCE)Anna Liza M P de Leeuw, Jordi Giralt, Yungan Tao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2019
Molecular Evolution of <i>IDH</i> Wild-Type Glioblastomas Treated With Standard of Care Affects Survival and Design of Precision Medicine Trials: A Report From the EORTC 1542 StudyKaspar Draaisma, Aikaterini Chatzipli, Martin Taphoorn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2021
Patients with Biallelic BRCA1/2 Inactivation Respond to Olaparib Treatment Across Histologic Tumor TypesHanneke van der Wijngaart, Louisa R Hoes, J Maxime van Berge Henegouwen, et al.
BMC Medical Genomics|November 5, 2022
Study protocol of the GLOW study: maximising treatment options for recurrent glioblastoma patients by whole genome sequencing-based diagnostics-a prospective multicenter cohort studyMark P van Opijnen, Marike L D Broekman, Filip Y F de Vos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2025
INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab Plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaJérôme Fayette, Lisa Licitra, Kevin Harrington, et al.
Head & Neck|August 11, 2016
Impact of chemotherapy on the outcome of osteosarcoma of the head and neck in adultsEline Boon, Winette T A van der Graaf, Hans Gelderblom, et al.
Clinical Nutrition (Edinburgh, Scotland)|December 9, 2021
Development and external validation of a prediction model for tube feeding dependency for at least four weeks during chemoradiotherapy for head and neck cancerAnna C H Willemsen, Annemieke Kok, Laura W J Baijens, et al.
International Journal of Cancer|March 2, 2018
A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The NetherlandsEline Boon, Miranda Bel, Wim van Boxtel, et al.
Pageof 8